The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Tonic endocannabinoid-mediated modulation of GABA release is independent of the CB1 content of axon terminals
Open accessAbstract
The release of GABA from cholecystokinin-containing interneurons is modulated by type-1 cannabinoid receptors (CB 1). Here we tested the hypothesis that the strength of CB 1-mediated modulation of GABA release is related to the CB 1 content of axon terminals. Basket cell boutons have on average 78% higher CB 1 content than those of dendritic-layer-innervating (DLI) cells, a consequence of larger bouton surface and higher CB 1 density. The CB 1 antagonist AM251 caused a 54% increase in action potential-evoked [Ca 2+] in boutons of basket cells, but not in DLI cells. However, the effect of AM251 did not correlate with CB 1 immunoreactivity of individual boutons. Moreover, a CB 1 agonist decreased [Ca 2+] in a cell type- and CB 1-content-independent manner. Replica immunogold labelling demonstrated the colocalization of CB 1 with the Cav2.2 Ca 2+ channel subunit. Our data suggest that only a subpopulation of CB 1 s, within nanometre distances from their target Cav2.2 channels, are responsible for endocannabinoid-mediated modulation of GABA release.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



![Figure 4 The CB 1 content of axon terminals in the distal CA3 is cell type-dependent, but independent of hippocampal layers. (a–d) Variability in the CB1 content of axon terminals of different cells. Post hoc immunohistochemical visualization of CB1 (green) in boutons (red) of in vitro [Ca2+] imaged and biocytin-filled GABAergic interneurons. Weakly (a,c) and strongly (b,d) CB1-immunopositive basket (a,b) and dendritic-layer-innervating (DLI, c,d) cells are shown. Lower panels display only the CB1 immunoreactivity (CB1-IR) for better visualization of the differences in the CB1 content. Arrows in upper and lower panels indicate the same boutons. (e) Basket cell axon terminals are stronger for CB1 than those of DLI cells in the distal CA3. The CB1-IR of biocytin-loaded boutons was normalized to the mean CB1 intensity of randomly selected non-biocytin-filled boutons in stratum pyramidale within the same section. (f–i) The strength of CB1-IR of boutons of a given cell is similar in different hippocampal layers. Both basket and DLI cells had axons in strata pyramidale (f,h) and radiatum (g,i). Lower panels show only the CB1-IR for better visualization of the differences in the CB1 content. (j) CB1-IR of axon terminals of individual cells is not significantly different in stratum pyramidale versus dendritic layers in basket and DLI cells. Error bars in e and j represent s.d. str. pyr., stratum pyramidale. Other str.: strata oriens, lucidum and radiatum. All scale bars, 2 μm. *denotes P<0.001.](https://figures.cochat.ai/paper-figures/76e0c0ca886d490d91dad72b7dc351fe/tonic-endocannabinoid-mediated-modulation-of-gaba-release-is-independent-of-the-figure-4.jpg)
![Figure 5 Action potential-evoked [Ca 2+ ] transients are smaller in axon terminals of basket compared with DLI cells. (a) Two-photon Z-stack maximum intensity projection image of a basket cell loaded with Alexa Fluor 594. (b) Confocal Z-stack maximum intensity projection image of the two-photon-imaged cell after fixation and visualization of the biocytin. (c) The imaged boutons from a are shown at a higher magnification with the corresponding [Ca2+] transients. The presented Ca2+ traces are the averages of two individual traces for each bouton. Note the variability in the peak transients within a bouton string. (d) Post hoc immunohistochemical visualization of CB1 (green) in the imaged and biocytin-filled (red) boutons. (e) Variability in action potential-evoked [Ca2+] transients in axon terminals of basket (imaged in stratum pyramidale) and DLI (imaged in strata radiatum or lucidum) cells. Every trace represents a single cell (averages of 18–30 individual traces). (f) [Ca2+] transients of DLI cells are significantly larger compared with basket cells. (g) Mean [Ca2+] transients measured in axon terminals in strata pyramidale and radiatum in a basket and a DLI cell. (h) Peak [Ca2+] transients in basket cell boutons are smaller in stratum pyramidale compared with the dendritic layers. Open symbols indicate independent measurements (individual cells measured in either layer), while filled symbols represent cells, in which boutons in both strata were measured (basket: n=8; DLI: n=4). * indicates significant difference (paired t-test, P<0.01, n=8) between strata pyramidale and dendritic layers for basket cells. (i) The amplitude of [Ca2+] transients is independent of the CB1 immunoreactivity of the cells when all cells are analysed together. When basket and DLI cells are analysed separately, significant positive correlation (Spearman correlation ρ=0.55, P=0.006) was found in baskets, but not in DLI cells. (j) No significant correlation was found between G/Gmax and CB1 content at the level of individual boutons in all analysed basket cells. Each cell is colour coded and open symbols represent individual boutons. Error bars in f and h represent s.d. A594, Alexa Fluor 594; str. pyr., stratum pyramidale. Other str.: strata oriens, lucidum and radiatum. Scale bars, 20 μm (a,b); 5 μm (c,d).](https://figures.cochat.ai/paper-figures/a5fd5ec135c64fd8b8fa2dc4bf4bb617/tonic-endocannabinoid-mediated-modulation-of-gaba-release-is-independent-of-the-figure-5.jpg)
![Figure 6 The CB 1 antagonist AM251 significantly increases [Ca 2+ ] transients in axon terminals of basket, but not those of DLI cells in the CA3 area. (a,b) The amplitude of [Ca2+] transients is larger in basket (a), but not in DLI cells (b) when [Ca2+] measurements were performed in 1 μM AM251 pre-incubated slices. (c–j) Effect of 100 nM AM251 on individual boutons in basket (c-f) and DLI cells (g–j) in stratum pyramidale (c,d,g,h) and in dendritic layers (e,f,i,j). The imaged boutons are labelled on the confocal Z-stack maximum intensity projection image (red, biocytin; green, CB1), and corresponding [Ca2+] transients are shown before (left traces) and after (right traces) AM251 application (c,e,g,i). Amplitude values of [Ca2+] transients recorded from individual boutons in control condition and after AM251 application are shown in d,f,h and j. AM251 significantly increases [Ca2+] transients in strata pyramidale (d, paired t-test, P=0.005, n=7 boutons) and lucidum (f, paired t-test, P=0.012, n=7 boutons) in basket cells. (k) AM251 effect on the amplitude of [Ca2+] transients at individual cells in strata pyramidale and lucidum/radiatum. Every symbol represents an individual cell. (l–m) The AM251 effect does not depend on either the peak [Ca2+] (l) or the relative CB1 content of the boutons (m). Measurements were performed in stratum pyramidale (circles) and radiatum/lucidum (triangles) for basket (black) and DLI (red) cells, respectively. When the correlation was analysed only for basket cells, no significant effect was seen. (n–o) Correlation analysis at the level of individual boutons revealed significant correlation between AM251 effect and G/Gmax in five out of nine cells (n). Each cell is colour coded and open symbols represent individual boutons. There was no correlation between AM251 effect and CB1 immunoreactivity in all analysed (n=7) cells (o). Error bars in a,b,d,f,h,j and k represent s.d. Scale bars, 5 μm (c,e,g,i). *denotes P<0.05.](https://figures.cochat.ai/paper-figures/a4a84262f6fc4088946c1c470c5d0a5d/tonic-endocannabinoid-mediated-modulation-of-gaba-release-is-independent-of-the-figure-6.jpg)
![Figure 7 Activation of the CB 1 significantly decreases [Ca 2+ ] transients in axon terminals of basket and DLI cells in the CA3 area. (a,b,d,e) Effect of the CB1 agonist WIN 55212-2 (10 and 100 nM) on [Ca2+] transients in individual basket (in stratum pyramidale) and DLI cells (in dendritic layers). The effect of 10 nM did not reach significance, but that of 100 nM was significant. (c,f) The WIN 55212-2 effect does not depend on the CB1 content of cells when analysis were either performed in all recorded cell (blue regression lines in c and f) or only for basket cells (black regression line in c). (g,h) The effect of 100 nM WIN 55212-2 can be reversed by the CB1 antagonist AM251 (1 μM). (i) The effect of 5 μM carbachol did not depend on the CB1 immunoreactivity of the cells. Error bars in b,e and h represent s.d. All scales for a,d and g are shown in d. *denotes P<0.05.](https://figures.cochat.ai/paper-figures/a9da8da703214ac180a8098d12456cbb/tonic-endocannabinoid-mediated-modulation-of-gaba-release-is-independent-of-the-figure-7.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Like CCKBCs, dendrite targeting CCK interneuron subtypes typically express CB1Rs (FIGURE 3B) (108, 289, 584, 594, 665, 1194).”
From Hippocampal GABAergic Inhibitory Interneurons (2017) · cites this paper as [665]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Südhof, T. C. (2004) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.26.041002.131412 · Cited by 2,547 · cited 1×
“The mechanisms of regulation of release have been extensively studied, revealing numerous mechanisms, including the direct or indirect modulation of presynaptic voltage-gated Ca 2+ or K + channels, or the modification of the release machinery through e.g. phosphorylation 11,15,16,17 .”
Role of Endogenous Cannabinoids in Synaptic Signaling
FREUND, T. F., KATONA, I., & PIOMELLI, D. (2003) · Physiological Reviews · doi:10.1152/physrev.00004.2003 · Cited by 1,574
Endocannabinoid Signaling in the Brain
Wilson, R. I., & Nicoll, R. A. (2002) · Science · doi:10.1126/science.1063545 · Cited by 1,260
Katona, I., Sperlágh, B., Sı́k, A., Käfalvi, A., Vizi, E. S., Mackie, K., & Freund, T. F. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-11-04544.1999 · Cited by 1,218 · cited 1×
“It is well known that CB 1 is strongly expressed by a diverse population of hippocampal CCK-positive (CCK+) INs in their axons 19 , resulting in a sparse axonal labeling of the hippocampal neuropil.”
Self-citationIncreased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice
Zimmer, A., Zimmer, A. M., Hohmann, A. G., Herkenham, M., & Bonner, T. I. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5780 · Cited by 1,064
Cell Type and Pathway Dependence of Synaptic AMPA Receptor Number and Variability in the Hippocampus
Nusser, Z., Lujan, R., Laube, G., Roberts, J. D. B., Molnar, E., & Somogyi, P. (1998) · Neuron · doi:10.1016/s0896-6273(00)80565-6 · Cited by 804
Self-citationPATON, W. D. M., & VIZI, E. S. (1969) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1969.tb07964.x · Cited by 704
Self-citationMultiple Functions of Endocannabinoid Signaling in the Brain
Katona, I., & Freund, T. F. (2012) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-062111-150420 · Cited by 630 · cited 1×
“The eCB causing this effect is either 2-arachidonoyl glycerol (2-AG) or anandamide 38,39,40 .”
Gulyas, A. I., Cravatt, B. F., Bracey, M. H., Dinh, T. P., Piomelli, D., Boscia, F., & Freund, T. F. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03428.x · Cited by 561 · cited 2×
“The hydrolyzing enzyme of 2-AG (monoacylglycerol lipase-α , MGL-α ) is also concentrated in the dendritic layers of the hippocampus, where it is located mainly in glutamatergic axons 42 .”
Molecular Composition of the Endocannabinoid System at Glutamatergic Synapses
Katona, I., Urbán, G. M., Wallace, M., Ledent, C., Jung, K.-M., Piomelli, D., Mackie, K., & Freund, T. F. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0309-06.2006 · Cited by 511
Cited by
Hippocampal GABAergic Inhibitory Interneurons
Pelkey, K. A., Chittajallu, R., Craig, M. T., Tricoire, L., Wester, J. C., & McBain, C. J. (2017) · Physiological Reviews · doi:10.1152/physrev.00007.2017 · Cited by 889
Determinants of different deep and superficial CA1 pyramidal cell dynamics during sharp-wave ripples
Valero, M., Cid, E., Averkin, R. G., Aguilar, J., Sanchez-Aguilera, A., Viney, T. J., Gomez-Dominguez, D., Bellistri, E., & de la Prida, L. M. (2015) · Nature Neuroscience · doi:10.1038/nn.4074 · Cited by 261
Single-cell RNAseq reveals cell adhesion molecule profiles in electrophysiologically defined neurons
Földy, C., Darmanis, S., Aoto, J., Malenka, R. C., Quake, S. R., & Südhof, T. C. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1610155113 · Cited by 179
Rebola, N., Reva, M., Kirizs, T., Szoboszlay, M., Lőrincz, A., Moneron, G., Nusser, Z., & DiGregorio, D. A. (2019) · Neuron · doi:10.1016/j.neuron.2019.08.014 · Cited by 136
Self-citationLee, S.-H., Ledri, M., Toth, B., Marchionni, I., Henstridge, C. M., Dudok, B., Kenesei, K., Barna, L., Szabo, S. I., Renkecz, T., et al. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.4112-14.2015 · Cited by 133
“distribution of their axonal arbors (Cope et al., 2002; Pawelzik et al., 2002; Klausberger and Somogyi, 2008; Nissen et al., 2010; Szabó et al., 2014b; Dudok et al., 2015; Lenkey et al., 2015).”
Background
Metadata
- Authors
- Lenkey, N., Kirizs, T., Holderith, N., Máté, Z., Szabó, G., Vizi, E. S., Hájos, N., & Nusser, Z.
- Affiliations
- HUN-REN Institute of Experimental Medicine (HU)
- Semmelweis University (HU)
- Venue
- Nature Communications
- Published
- 2015-04-20
- Volume
- 6
- Issue
- 1
- Pages
- 6557-6557
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC4413030
- OpenAlex
- W2041300659
- Cited by
- 45
- References
- 51
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 2 · 2023: 1 · 2022: 3 · 2021: 6 · 2020: 2 · 2019: 8 · 2018: 3 · 2017: 9 · 2016: 5 · 2015: 3
- FWCI
- 4.80
- Type
- journal article
- Language
- en
- Update notices
- correction (2015-08-26)
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Repository of the Academy's Library (Library of the Hungarian Academy of Sciences) (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- University of Debrecen Electronic Archive (University of Debrecen) (submittedVersion)
- University of Debrecen Electronic Archive (University of Debrecen) (submittedVersion, other-oa)
- Funders
- Wellcome Trust (094513, WT094513)
- Magyar Tudományos Akadémia (LP2012-29, LP2012‐23)
- Nemzeti Kutatási és Technológiai Hivatal (OMFB-01678/2009)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- endocannabinoids, CB1 receptor, GABA release, cholecystokinin interneurons, basket cells, axon terminals, calcium imaging, AM251, CB1 agonists, receptor colocalization, tonic inhibition
- MeSH terms
- Red Fluorescent Protein, Animals, Animals, Newborn, Calcium, Female, gamma-Aminobutyric Acid, Hippocampus, Luminescent Proteins, Male, Mice, Transgenic, Neurons, Presynaptic Terminals, Receptor, Cannabinoid, CB1, Mice, Endocannabinoids
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Tonic endocannabinoid-mediated modulation of GABA release is independent of the CB1 content of axon terminals. https://app.cochat.ai/papers/10.1038/ncomms7557
- The paper
- Lenkey, N., Kirizs, T., Holderith, N., Máté, Z., Szabó, G., Vizi, E. S., Hájos, N., & Nusser, Z. (2015). Tonic endocannabinoid-mediated modulation of GABA release is independent of the CB1 content of axon terminals. Nature Communications. https://doi.org/10.1038/ncomms7557
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.